CDNA — CareDx, Inc | SharesGrow.com

CareDx, Inc (CDNA) 是一家 Medical - Diagnostics & Research 公司，屬於醫療保健產業, 目前交易價格為 $17.63. 其SharesGrow評分為 60/100, 表明高於平均的投資特徵， 7項中通過3項.

SharesGrow calculates the intrinsic value of CDNA = $629.37 (+3469.9% 相對於當前價格, 該股票看起來被低估). 分析師共識目標價為 CDNA = $23 (+32.3% 上漲空間).

估值: CDNA 本益比(P/E)為 -40.5 (S&P 500平均約25) 前瞻PEG為 0.08.

財務數據: 營收為 $380M, +6.7%/yr 平均成長. 淨利潤為 $21M (虧損), 成長率為 -53.8%/yr. 淨利潤率為 -5.6% (負值). 毛利率為 67% (+1.9 pp 趨勢).

資產負債表: 總債務為 $20M 對比 $303M 股東權益 (D/E比率 0.06, 保守). 流動比率為 2.86 (流動性強). 資產負債率為 4.8%. 總資產: $413M.

分析師展望: 10 / 13 位分析師評級 CDNA 為買入 (77%) — 強烈共識.

SharesGrow 7項標準細分: Value 97/100 (Pass), Growth 40/100 (Partial), Past 25/100 (Fail), Health 100/100 (Pass), Moat 60/100 (Partial), Future 85/100 (Pass), Income 10/100 (Fail).

$23.33

▲ 32.33% 上漲空間

Average Price Target

基於 13 位華爾街分析師對 CareDx, Inc 提供的12個月價格目標，平均目標價為 $23.33，最高預測為 $26.00，最低預測為 $18.00。

Highest Price Target

$26.00

Average Price Target

$23.33

Lowest Price Target

$18.00

CDNA SharesGrow 評分概覽

60/100

SharesGrow Score

Above average fundamentals

View full scorecard →

價值 97/100

估值 — P/E, PEG, Forward PEG

成長 40/100

財務數據 — 平均成長

過去 25/100

強勁 — 趨勢

健康 100/100

資產負債表 — D/E比率, 流動比率為

護城河 60/100

毛利率為 + market cap

未來 85/100

分析師展望 — 為買入

收入 10/100

淨利潤率為

Scores derived from financial statements, analyst ratings, and balance sheet data.

評分明細 — CDNA

✓

價值 Pass

97/100

CDNA 本益比(P/E)為 -40.5 (S&P 500平均約25). Forward PEG 0.08 — Peter Lynch 被低估 (≤1.0). Trailing PEG 0.31. 分析師共識目標價為 $23, 意味著 +30.5% 相對於當前價格 $18. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + 上漲空間 (25%) + trailing PEG (20%). ≥ 60 = Pass.

CDNA: +6.7%/yr 營收為, -53.8%/yr 淨利潤為平均成長. 一般. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

CDNA: 1 / 4 年獲利. 較弱. Score = 1 / 4 × 100. ≥ 80 = Pass.

資產負債表 CDNA: D/E比率 0.06 (保守), 流動比率為 2.86 (流動性強). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

CDNA: 毛利率為 67% (+1.9 pp 趨勢), N/A market cap. Moat (0-100): margin (35%) + 趨勢 (15%) + market cap (30%) + 營收為 (20%). Score 60/100. ≥ 70 = Pass.

分析師展望: 10 / 13 位分析師評級 CDNA 為買入 (77%). 分析師共識目標價為 $23 (+30.5% 上漲空間). Score: 60% buy consensus + 40% 上漲空間. ≥ 60 = Pass.

CDNA: 淨利潤率為 -5.6%. 負值. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

市場數據

52週區間10.96-21.485

成交量580.19K

30日平均成交量633.27K

市值$906.76M

Beta（1年）2.54

Share Statistics

EPS（TTM）-0.40

流通股數$53.29M

IPO Date2014-07-17

Employees644

CEOJohn Walter Hanna Jr.

Financial Highlights & Ratios

Revenue (TTM)$379.81M

Gross Profit$254.43M

EBITDA$-667K

Net Income$-21.35M

Operating Income$-21.02M

Total Cash$177.21M

Total Debt$19.68M

Net Debt$-45.75M

Total Assets$413.23M

Price / Earnings (P/E)-44.1

Price / Sales (P/S)2.39

Analyst Forecast

1Y Price Target$26.00

Target High$26.00

Target Low$18.00

上漲空間+47.5%

評級共識Buy

覆蓋分析師數13

買入 77% 持有 23% 賣出 0%

Price Target Summary

公司資訊

國家US

交易所NASDAQ Global Market

貨幣USD

ISINUS14167L1035

股價走勢

CDNA

CareDx, Inc ↗ · NASDAQ Global Market

Healthcare • Medical - Diagnostics & Research

10.96 52WK RANGE 21.49

其他人也在看

Exact Sciences Corporation

Guardant Health, Inc.

$86.40

+5.10%

CRL

Charles River Laboratories International, Inc.

$179.31

+0.54%

TWST

Twist Bioscience Corporation

$57.41

+13.95%

CSTL

Castle Biosciences, Inc.

CareDx, Inc CDNA NASDAQ

CDNA SharesGrow 評分概覽

評分明細 — CDNA

Stock Chart & Stats

股價走勢

其他人也在看

獲取低估股票提醒